Antifungal susceptibility of cryptococcus neoformans clinical isolates from different cities of Argentina

被引：0
|
作者：
Theill, L. [1 ]
Frola, C. [2 ]
Leonardelli, F. [1 ]
Guelfand, L. [2 ]
Macedo, D. [1 ]
Cabeza, M. [1 ]
Dudiuk, C. [3 ]
Garcia-Effron, G. [1 ]
Gamarra, M. S. [1 ]
机构：
[1] Univ Nacl Litoral, Lab Micol & Diagnost Mol, CONICET, Catedra Parasitol & Micol,Fac Bioquim, Santa Fe, Argentina
[2] Hosp Fernandez, Microbiol, Buenos Aires, DF, Argentina
[3] Lab Micol & Diagnost Mol, Santa Fe, Argentina
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2018年 / 73卷
关键词：
D O I：
10.1016/j.ijid.2018.04.4042
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
UMP. 489
引用
收藏
页码：275 / 275
页数：1
相关论文
共 50 条
  • [41] In Vitro Susceptibility of Environmental Cryptococcus neoformans Variety neoformans Isolates from Turkey to Six Antifungal Agents, Including SCH56592 and Voriconazole
    S. T. Yildiran
    M. A. Saracli
    A. W. Fothergill
    M. G. Rinaldi
    European Journal of Clinical Microbiology and Infectious Diseases, 2000, 19 : 317 - 319
  • [42] The interaction of macrophages with different Cryptococcus neoformans isolates
    Filippova, L. V.
    Vasilyeva, N. V.
    Kiseleva, E. P.
    Frolova, E. V.
    Uchevatkina, A. E.
    MYCOSES, 2009, 52 : 91 - 92
  • [43] Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents
    Poonwan, N
    Mikami, Y
    Poosuwan, S
    BoonLong, J
    Mekha, N
    Kusum, M
    Yazawa, K
    Tanaka, R
    Nishimura, K
    Konyama, K
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1997, 13 (03) : 335 - 340
  • [44] Genotypic diversity and antifungal susceptibility of environmental isolates of Cryptococcus neoformans from the Yangtze River Delta region of East China
    Chen, Min
    Wang, Yan
    Li, Yingfang
    Hong, Nan
    Zhu, Xinlin
    Pan, Weihua
    Liao, Wanqing
    Xu, Jianping
    Du, Jingxia
    Chen, Jianghan
    MEDICAL MYCOLOGY, 2021, 59 (07) : 653 - 663
  • [45] Temporal trends in antifungal susceptibility of Cryptococcus neoformans isolates from a reference laboratory in the United States, 2011-2021
    Ordaya, Eloy E.
    Abu Saleh, Omar M.
    Vergidis, Paschalis
    Deml, Sharon M.
    Wengenack, Nancy L.
    Fida, Madiha
    MYCOSES, 2024, 67 (01)
  • [46] Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility
    Liaw, S-J
    Wu, H-C
    Hsueh, P-R
    CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (06) : 696 - 703
  • [47] Importance of Clinical Isolates in Cryptococcus neoformans Research
    Jackson, Katrina M.
    Ding, Minna
    Nielsen, Kirsten
    JOURNAL OF FUNGI, 2023, 9 (03)
  • [48] Antifungal susceptibility, serotyping, and genotyping of clinical Cryptococcus neoformans isolates collected during 18 years in a single institution in Madrid, Spain
    Guinea, Jesus
    Hagen, Ferry
    Pelaez, Teresa
    Boekhout, Teun
    Tahoune, Hicham
    Torres-Narbona, Marta
    Bouza, Emilio
    MEDICAL MYCOLOGY, 2010, 48 (07) : 942 - 948
  • [49] Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States:: 1992 to 1994 and 1996 to 1998
    Brandt, ME
    Pfaller, MA
    Hajjeh, RA
    Hamill, RJ
    Pappas, PG
    Reingold, AL
    Rimland, D
    Warnock, DW
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) : 3065 - 3069
  • [50] Fluconazole tolerance in clinical isolates of Cryptococcus neoformans
    Venkateswarlu, K
    Taylor, M
    Manning, NJ
    Rinaldi, MG
    Kelly, SL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (04) : 748 - 751
12345